echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > The prevention and control rate of bivalent HPV vaccine reaches 84.5%. It is recommended to vaccinate as soon as possible

    The prevention and control rate of bivalent HPV vaccine reaches 84.5%. It is recommended to vaccinate as soon as possible

    • Last Update: 2021-08-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    China News Service, Guangzhou, July 18 (Cai Minjie and He Yuhang) The current cervical cancer vaccines include domestically produced two-valent, imported two-valent, four-valent, and nine-valent vaccines


    Human papillomavirus is abbreviated as HPV, which is the main cause of cervical cancer


    In 2018, the World Health Organization called for the global elimination of cervical cancer.


    Cervical cancer is preventable and controllable and requires early vaccination and early protection


    Studies have shown that more than 84.


    In December 2019, the National Medical Products Administration approved Xiamen Wantai Biotech's bivalent human papillomavirus vaccine to be marketed


    Wang Ming said that cervical cancer is currently the only malignant tumor with a clear etiology, preventable and controllable.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.